Innovative Platforms for Haploidentical Stem Cell Transplantation: The Role of Unmanipulated Donor Graft
<p>We exploited the dual positive effects of rapamycin to prevent GvHD and control malignant cells upon infusion of unmanipulated grafts from family haploidentical donors to patients affected by advanced hematological malignancies. Preliminary results on 45 patients show the feasibility of thi...
Main Author: | Fabio Ciceri, Marco Bregni, Jacopo Peccatori |
---|---|
Format: | Article |
Language: | English |
Published: |
Ivyspring International Publisher
2011-01-01
|
Series: | Journal of Cancer |
Online Access: | http://www.jcancer.org/v02p0339.htm |
Similar Items
-
A comparison between allogeneic stem cell transplantation from unmanipulated haploidentical and unrelated donors in acute leukemia
by: Simona Piemontese, et al.
Published: (2017-01-01) -
Allogeneic Stem Cell Transplantation for Metastatic Renal Cell Cancer (RCC)
by: Marco Bregni, Fabio Ciceri, Jacopo Peccatori
Published: (2011-01-01) -
Granulocyte Colony-Stimulating Factor-Primed Unmanipulated Haploidentical Blood and Marrow Transplantation
by: Ying-Jun Chang, et al.
Published: (2019-11-01) -
Efficacy and Safety of Unmanipulated Haploidentical Related Donor Allogeneic Peripheral Blood Stem Cell Transplantation in Patients with Relapsed/Refractory Acute Myeloid Leukemia
by: Li-Ping Dou, et al.
Published: (2018-01-01) -
Leukemia relapse following unmanipulated haploidentical transplantation: a risk factor analysis on behalf of the ALWP of the EBMT
by: Simona Piemontese, et al.
Published: (2019-07-01)